Literature DB >> 17306421

Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells.

Mireia Coma1, Francesc X Guix, Gerard Ill-Raga, Iris Uribesalgo, Francesc Alameda, Miguel A Valverde, Francisco J Muñoz.   

Abstract

Cerebral amyloid angiopathy, associated to most cases of Alzheimer's disease (AD), is characterized by the deposition of amyloid ss-peptide (Ass) in brain vessels, although the origin of the vascular amyloid deposits is still controversial: neuronal versus vascular. In the present work, we demonstrate that primary cultures of human cerebral vascular smooth muscle cells (HC-VSMCs) have all the secretases involved in amyloid ss-protein precursor (APP) cleavage and produce Ass(1-40) and Ass(1-42). Oxidative stress, a key factor in the etiology and pathophysiology of AD, up-regulates ss-site APP cleaving enzyme 1 (BACE1) expression, as well as Ass(1-40) and Ass(1-42) secretion in HC-VSMCs. This process is mediated by c-Jun N-terminal Kinase and p38 MAPK signaling and appears restricted to BACE1 regulation as no changes in the other secretases were observed. In conclusion, oxidative stress-mediated up-regulation of the amyloidogenic pathway in human cerebral vascular smooth muscle cells may contribute to the overall cerebrovascular amyloid angiopathy observed in AD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306421     DOI: 10.1016/j.neurobiolaging.2007.01.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  25 in total

1.  Endothelium-specific amyloid precursor protein deficiency causes endothelial dysfunction in cerebral arteries.

Authors:  Livius V d'Uscio; Tongrong He; Anantha V Santhanam; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-29       Impact factor: 6.200

Review 2.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

3.  Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid.

Authors:  Susan A Austin; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-07       Impact factor: 6.200

4.  7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

5.  Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain.

Authors:  Xike Qin; Yunling Wang; Hemant K Paudel
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

6.  Lower serum uric acid levels in cerebral amyloid angiopathy: a pilot study.

Authors:  Qi Hu; Anding Liu; Mengyang Huang; Luo Cheng; Huicong Kang; Feng Xu; Xiaoyan Liu; Lifei Lian; Qiming Liang; Hong Jiang; Cuntai Zhang; Suiqiang Zhu
Journal:  Neurol Sci       Date:  2014-01-25       Impact factor: 3.307

Review 7.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

8.  The progesterone receptor regulates the expression of TRPV4 channel.

Authors:  Carole Jung; César Fandos; Ivan M Lorenzo; Cristina Plata; Jacqueline Fernandes; Gemma G Gené; Esther Vázquez; Miguel A Valverde
Journal:  Pflugers Arch       Date:  2009-08-23       Impact factor: 3.657

9.  Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.

Authors:  Jason Lockrow; Annamalai Prakasam; Peng Huang; Heather Bimonte-Nelson; Kumar Sambamurti; Ann-Charlotte Granholm
Journal:  Exp Neurol       Date:  2008-12-10       Impact factor: 5.330

10.  Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease.

Authors:  Francesc X Guix; Tina Wahle; Kristel Vennekens; An Snellinx; Lucía Chávez-Gutiérrez; Gerard Ill-Raga; Eva Ramos-Fernandez; Cristina Guardia-Laguarta; Alberto Lleó; Muriel Arimon; Oksana Berezovska; Francisco J Muñoz; Carlos G Dotti; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2012-05-02       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.